Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.
Roozbeh HeidarzadehpilehroodMaryam PirhoushiaranMalina OsmanKing-Hwa LingHabibah Abdul HamidPublished in: Iranian journal of pharmaceutical research : IJPR (2023)
The findings from this study might assist researchers in uncovering new biomarkers and potential therapeutic drug targets in PCOS treatment.